Public Profile

Encysive GmbH

Encysive GmbH, a prominent player in the biotechnology sector, is headquartered in Germany and operates extensively across Europe. Founded in 2001, the company has established itself as a leader in developing innovative therapeutic solutions, particularly in the fields of cardiovascular and pulmonary diseases. Encysive's core offerings include advanced drug formulations and delivery systems that are distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including successful clinical trials and partnerships with major pharmaceutical firms, solidifying its position in the competitive biotech landscape. With a commitment to research and development, Encysive GmbH continues to push the boundaries of medical science, striving to improve patient outcomes and enhance the quality of life for those affected by chronic conditions.

DitchCarbon Score

How does Encysive GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

47

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Encysive GmbH's score of 47 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

Let us know if this data was useful to you

Encysive GmbH's reported carbon emissions

Encysive GmbH, headquartered in Germany, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that Encysive GmbH may still be in the early stages of formalising its climate commitments or reporting its carbon footprint. In the context of the industry, it is increasingly important for companies to establish clear climate strategies and reduction targets to align with global sustainability goals. As such, Encysive GmbH may benefit from developing and communicating its climate initiatives to enhance transparency and accountability in its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Encysive GmbH's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Encysive GmbH is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Encysive GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers